Biocon’s Pertuzumab Biosimilar Receives Positive EMA CHMP Opinion Under New Tailored Clinical Approach
Biocon Biologics’ pertuzumab biosimilar, Pebrilzo®, has received...
From Tuberculosis Research to Leading Functional Immunology and Vaccine Development in the Biotech Industry
Dr. Mehak Zahoor Khan is an bacterial immunologist and biomarker scientist...